Process Evaluation to Document Crucial Moments in Development of the National Neurological Conditions Surveillance System at the U.S. Centers for Disease Control and Prevention

Main Article Content

Goldie MacDonald
https://orcid.org/0000-0001-5773-5401
Shawna L Mercer
https://orcid.org/0000-0002-3685-3713
Angela H Fisher
Violanda Grigorescu
https://orcid.org/0000-0001-9168-0280
William R Mac Kenzie
https://orcid.org/0000-0001-7723-0339
Mindelyn Anderson
https://orcid.org/0000-0002-4636-3195

Abstract

Background: Neurological conditions or disorders strike roughly 50 million Americans annually but accurate and comprehensive national estimates for many of these conditions are not available. In 2019, Congress provided $5 million to Centers for Disease Control and Prevention (CDC) to establish the National Neurological Conditions Surveillance System (NNCSS). CDC focused initial activities on multiple sclerosis and Parkinson’s disease.


Purpose: We conducted a process evaluation to document and understand multifaceted work to implement a new surveillance activity for two neurological conditions.


Setting: We conducted this evaluation with government personnel internal to the Center for Surveillance, Epidemiology, and Laboratory Services at the Centers for Disease Control and Prevention in Atlanta, GA.


Intervention: A new public health surveillance activity for two neurological conditions, multiple sclerosis and Parkinson’s disease, that uses existing data resources and systems.


Research design: The evaluation included interviews with CDC personnel and review of administrative and programmatic information. Data were analyzed and interpreted to identify crucial moments in the first year of funded work on NNCSS. The study revealed that this surveillance activity required diverse contributions and collaboration within the federal government and with non-governmental organizations. The findings can be used to guide work to enhance surveillance for many neurological conditions.


Findings: The study revealed that this surveillance activity required diverse contributions and collaboration within the federal government and with non-governmental organizations. While collaboration is a cornerstone of public health practice, it is not always well-documented in planning or implementation of surveillance or other data-related activities.

Downloads

Download data is not yet available.

Article Details

How to Cite
MacDonald, G., Mercer, S. L., Fisher, A. H., Grigorescu, V., Mac Kenzie, W. R., & Anderson, M. (2020). Process Evaluation to Document Crucial Moments in Development of the National Neurological Conditions Surveillance System at the U.S. Centers for Disease Control and Prevention. Journal of MultiDisciplinary Evaluation, 16(35), 48–53. https://doi.org/10.56645/jmde.v16i35.635
Section
Ideas to Consider in Evaluation

References

21st Century Cures Act of 2016, Pub. L. No. 114-255, 130 Stat. 1034. Facilitating Collaborative Research, National neurological conditions surveillance system, Sec. 2061. https://www.congress.gov/114/plaws/publ255/PLAW-114publ255.pdf (2016).

Centers for Disease Control and Prevention. (2008). Introduction to Process Evaluation in Tobacco Use Prevention and Control. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Retrieved May 21, 2020 from https://www.cdc.gov/tobacco/stateandcommunity/tobacco_control_programs/surveillance_evaluation/process_evaluation/pdfs/tobaccousemanual_updated04182008.pdf

Centers for Disease Control and Prevention. (2018, September). Public Health Surveillance: Preparing for the Future. U.S. Department of Health and Human Services. Retrieved May 21, 2020 from https://www.cdc.gov/surveillance/pdfs/Surveillance-Series-Bookleth.pdf

Centers for Disease Control and Prevention. (2020a, May 13). National Neurological Conditions Surveillance System. U.S. Department of Health and Human Services. https://www.cdc.gov/surveillance/projects/nncss/index.html

Centers for Disease Control and Prevention. (2020b, April 16). National Neurological Conditions Surveillance System (NNCSS) Logic Model. U.S. Department of Health and Human Services. Retrieved May 20, 2020 from https://www.cdc.gov/surveillance/docs/NNCSS_Logic_Model.pdf

Division of Health Informatics and Surveillance. (2019, December 2). DHIS Overview. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. https://www.cdc.gov/csels/dhis/overview.html

Frieden, T. R. (2014). Six components necessary for effective public health program implementation. American Journal of Public Health, 104(1), 17-22. https://doi.org/10.2105/AJPH.2013.31608 DOI: https://doi.org/10.2105/AJPH.2013.301608

Limbani, F., Goudge, J., Joshi, R., Maar, M. M., Miranda, J. J., Oldenburg, B., Parker, G., Pesantes, A. A., Riddell, M. A., Salam, A., Trieu, K., Thrift, A. G., Van Olmen, J., Vedanthan, R., Webster, R., Yeates, K., Webster, J., & Global Alliance for Chronic Diseases, Process Evaluation Working Group. (2019). Process evaluation in the field: Global learnings from seven implementation research hypertension projects in low-and middle-income countries. BioMed Central Public Health, 19(1), Article 953. https://doi.org/10.1186/s12889-019-7261-8 DOI: https://doi.org/10.1186/s12889-019-7261-8

Moore, G. F., Audrey, S., Barker, M., Bond, L., Bonell, C., Hardeman, W., Moore, L., O'Cathain, A., Tinati, T., Wight, D., & Baird, J. (2015). Process evaluation of complex interventions: Medical Research Council guidance. British Medical Journal, Article 350:h1258. https://doi.org/10.1136/bmj.h1258 DOI: https://doi.org/10.1136/bmj.h1258

National Institute of Neurological Disorders and Stroke. (2019, August 13). Hope Through Research. Retrieved February 26, 2020 from https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Hope-Through-Research

Patton, M. Q. (2008). Utilization-focused evaluation (4th ed). SAGE Publications.

Pringsheim, T., Fiest, K., & Jette, N. (2014). The international incidence and prevalence of neurologic conditions: How common are they? Neurology, 83(18), 1661-1664. https://doi.org/10.1212/WNL.0000000000000929 DOI: https://doi.org/10.1212/WNL.0000000000000929